IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $812,000 | +10.5% | 17,907 | 0.0% | 0.12% | +41.2% |
| Q2 2023 | $735,000 | +12.6% | 17,907 | -2.0% | 0.08% | +4.9% |
| Q1 2023 | $653,000 | -6.8% | 18,268 | -1.6% | 0.08% | -19.8% |
| Q4 2022 | $701,000 | -55.9% | 18,563 | -48.3% | 0.10% | -62.6% |
| Q3 2022 | $1,590,000 | +10.3% | 35,939 | -7.7% | 0.27% | +2.7% |
| Q2 2022 | $1,441,000 | -11.8% | 38,922 | -11.8% | 0.26% | 0.0% |
| Q1 2022 | $1,634,000 | +84.2% | 44,120 | +51.3% | 0.26% | +92.0% |
| Q4 2021 | $887,000 | +131.6% | 29,161 | +155.1% | 0.14% | +121.0% |
| Q3 2021 | $383,000 | – | 11,432 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |